https://orcid.org/0000-0002-8875-9665
References
- Strong MJ. Revisiting the concept of amyotrophic lateral sclerosis as a multisystems disorder of limited phenotypic expression. Curr Opin Neurol. 2017;30(6):599–607.
- Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med. 2001;344(22):1688–1700.
- Roth CR, Glaze LE, Goding GS, et al. Spasmodic dysphonia symptoms as initial presentation of amyotrophic lateral sclerosis. J Voice. 1996;10(4):362–367.
- Tomik B, Guiloff RJ. Dysarthria in amyotrophic lateral sclerosis: a review. Amyotroph Lateral Scler. 2010;11(1–2):4–15.
- Caligari M, Godi M, Guglielmetti S. Eye tracking communication devices in amyotrophic lateral sclerosis: impact on disability and quality of life. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(7–8):546–552.
- Ward AL, Sanjak M, Duffy K, et al. Power wheelchair prescription, utilization, satisfaction, and cost for pts with amyotrophic lateral sclerosis: preliminary data for evidence-based guidelines. Arch Phys Med Rehabil. 2010;91(2):268–272.
- Ding D, Leister E, Cooper RA, et al. Usage of tilt-in-space, recline, and elevation seating functions in natural environment of wheelchair users. J Rehabil Res Dev. 2008;45(7):973–983.
- Sonenblum SE, Sprigle S, Maurer CL. Use of power tilt systems in everyday life. Disabil Rehabil Assist Technol. 2009;4(1):24–30.
- Cooley M. Human-centred Systems. Designing Human-centred Technology. The Springer Series on Artificial Intelligence and Society; 1989; p. 133–143.
- Brooks BR, Miller RG, Swash M, et al. World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293–299.
- Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169(1–2):13–21.
- EYETRACKING [internet]. Lisbon: Lusovu, Lda; 2015. [cited 2019 Feb 19]. Available from www.myeyespeak.com.
- Sguazzin C, Giorgi I, Alesii A, et al. Italian validation of the McGill Quality of Life Questionnaire (MQOL-It)). G Ital Med Lav Ergon. 2010;32(3 Suppl B):B58–62.
- Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain. 1975;1(3):277–299.
- Wessels RD, de Witte L, Andrich R, et al. IPPA, a user-centred approach to assess effectiveness of assistive technology provision. Technol Disabil. 2001;13(2):105.
- Light J. Interaction involving individuals using augmentative and alternative communication systems: state of the art and future directions. Augment Altern Comm. 1988;4(2):66–82.
- Wessels R, Persson J, Lorentsen O, et al. IPPA: individually prioritized problem assessment. Technol Disabil. 2002;14(3):141–145.
- Jutai J, Day H. Psychosocial Impact of Assistive Devices Scale (PIADS). Technol Disabil. 2002;14(3):107–111.
- Novak M, Guest C. Application of a multidimensional caregiver burden inventory. Gerontologist. 1989;29(6):798–803.
- Janssen S, Bolte B, Nonnekes J, et al. Usability of Three-dimensional augmented visual cues delivered by smart glasses on (Freezing of) gait in Parkinson's Disease. Front Neurol. 2017;13(8):279.
- Ahn D, Chung H, Lee HW, et al. Smart Gait-Aid glasses for parkinson's disease patients. IEEE Trans Biomed Eng. 2017;64(10):2394–2402.
- Zhao Y, Heida T, van Wegen EE, et al. E-health support in people with parkinson's disease with smart glasses: a survey of user requirements and expectations in the Netherlands. J Parkinsons Dis. 2015;5(2):369–378.